HK1008527A1 - 4-aminotetrahydrobenzisoxazole or-isothiazole compounds - Google Patents

4-aminotetrahydrobenzisoxazole or-isothiazole compounds

Info

Publication number
HK1008527A1
HK1008527A1 HK98109349A HK98109349A HK1008527A1 HK 1008527 A1 HK1008527 A1 HK 1008527A1 HK 98109349 A HK98109349 A HK 98109349A HK 98109349 A HK98109349 A HK 98109349A HK 1008527 A1 HK1008527 A1 HK 1008527A1
Authority
HK
Hong Kong
Prior art keywords
aminotetrahydrobenzisoxazole
disorders
isothiazole compounds
disease
aminotetrahydrobenzisoxazoles
Prior art date
Application number
HK98109349A
Other languages
English (en)
Inventor
Erik Falch
Jens Kristian Perregarrd
Arne Schousboe
Povl Krogsgaard-Larsen
Bente Frolund
Lenz Sibylle Moltzen
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of HK1008527A1 publication Critical patent/HK1008527A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nozzles (AREA)
HK98109349A 1995-02-28 1998-07-22 4-aminotetrahydrobenzisoxazole or-isothiazole compounds HK1008527A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK20795 1995-02-28
PCT/DK1996/000084 WO1996026929A1 (en) 1995-02-28 1996-02-28 4-aminotetrahydrobenzisoxazole or -isothiazole compounds

Publications (1)

Publication Number Publication Date
HK1008527A1 true HK1008527A1 (en) 1999-07-30

Family

ID=8090951

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98109349A HK1008527A1 (en) 1995-02-28 1998-07-22 4-aminotetrahydrobenzisoxazole or-isothiazole compounds

Country Status (31)

Country Link
US (2) US5998613A (sk)
EP (1) EP0812318B1 (sk)
JP (1) JPH11501016A (sk)
KR (1) KR100242675B1 (sk)
CN (1) CN1087290C (sk)
AT (1) ATE317391T1 (sk)
AU (1) AU697610B2 (sk)
BG (1) BG63258B1 (sk)
BR (1) BR9607443A (sk)
CA (1) CA2213127A1 (sk)
CZ (1) CZ290837B6 (sk)
DE (1) DE69635798T2 (sk)
DK (1) DK0812318T3 (sk)
EA (1) EA000380B1 (sk)
EE (1) EE03483B1 (sk)
ES (1) ES2253748T3 (sk)
FI (1) FI973519A0 (sk)
HK (1) HK1008527A1 (sk)
HU (1) HUP9800631A3 (sk)
IL (1) IL117295A (sk)
IS (1) IS2352B (sk)
NO (1) NO309474B1 (sk)
NZ (1) NZ301653A (sk)
PL (1) PL187404B1 (sk)
RO (1) RO119545B1 (sk)
SI (1) SI0812318T1 (sk)
SK (1) SK281879B6 (sk)
TR (1) TR199700873T1 (sk)
UA (1) UA43396C2 (sk)
WO (1) WO1996026929A1 (sk)
ZA (1) ZA961591B (sk)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100491282B1 (ko) 1996-07-24 2005-05-24 워너-램버트 캄파니 엘엘씨 통증 치료용 이소부틸가바 및 그의 유도체
GB9622370D0 (en) 1996-10-28 1997-01-08 Merck Sharp & Dohme Therapeutic agents
US20030185754A1 (en) * 2001-01-16 2003-10-02 Genset, S.A. Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists
US20030166554A1 (en) * 2001-01-16 2003-09-04 Genset, S.A. Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists
US7417040B2 (en) * 2004-03-01 2008-08-26 Bristol-Myers Squibb Company Fused tricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
US7378426B2 (en) * 2004-03-01 2008-05-27 Bristol-Myers Squibb Company Fused heterotricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
CN102414208B (zh) * 2009-05-05 2014-11-05 霍夫曼-拉罗奇有限公司 作为用于认知性障碍的治疗中的gaba a受体逆激动剂的异*唑-噻唑衍生物
EP2445343B1 (en) 2009-06-25 2021-08-04 Alkermes Pharma Ireland Limited Prodrugs of nh-acidic compounds
CN105758807B (zh) * 2016-02-22 2019-01-29 山东出入境检验检疫局检验检疫技术中心 一种鉴别废润滑油的方法
US11273158B2 (en) 2018-03-05 2022-03-15 Alkermes Pharma Ireland Limited Aripiprazole dosing strategy

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2602643C2 (de) * 1976-01-24 1984-12-20 Bayer Ag, 5090 Leverkusen 1,2-Benzisothiazolinone-3, Verfahren zu ihrer Herstellung sowie Arzneimittel
US4411901A (en) * 1981-12-23 1983-10-25 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4452799A (en) * 1981-12-23 1984-06-05 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4514414A (en) * 1982-10-25 1985-04-30 Smithkline Beckman Corporation N-Substituted pyrrolidineacetic acids and their esters
US4804663A (en) 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
DK288385D0 (da) * 1985-06-26 1985-06-26 Novo Industri As Aminosyrederivater
US5321037A (en) * 1986-12-26 1994-06-14 Sankyo Company, Limited Isoxazole derivatives for use as cerebro-active drugs and central muscle relaxants
IE60267B1 (en) * 1986-12-26 1994-06-29 Sankyo Co Centrally-acting muscle relaxants
US5225412A (en) * 1991-04-29 1993-07-06 Hoechst-Roussel Pharmaceuticals Incorporated Benzoisothiazole-and benzisoxazole-3-carboxamides
US5143923B1 (en) * 1991-04-29 1993-11-02 Hoechst-Roussel Pharmaceuticals Incorporated Benzoisothiazole-and benzisoxazole-3-carboxamides

Also Published As

Publication number Publication date
NO973948D0 (no) 1997-08-27
US6174909B1 (en) 2001-01-16
TR199700873T1 (xx) 1998-01-21
ES2253748T3 (es) 2006-06-01
FI973519A (fi) 1997-08-27
DE69635798T2 (de) 2006-08-17
CN1176638A (zh) 1998-03-18
IL117295A (en) 1999-11-30
IL117295A0 (en) 1996-06-18
MX9706280A (es) 1998-06-30
CZ271197A3 (cs) 1998-03-18
KR19980702546A (ko) 1998-07-15
EA000380B1 (ru) 1999-06-24
FI973519A0 (fi) 1997-08-27
HUP9800631A2 (hu) 1998-08-28
KR100242675B1 (ko) 2000-03-02
CN1087290C (zh) 2002-07-10
EP0812318A1 (en) 1997-12-17
RO119545B1 (ro) 2004-12-30
IS4542A (is) 1997-08-13
EE9700197A (et) 1998-02-16
ATE317391T1 (de) 2006-02-15
NZ301653A (en) 1998-12-23
JPH11501016A (ja) 1999-01-26
WO1996026929A1 (en) 1996-09-06
BR9607443A (pt) 1998-05-26
PL187404B1 (pl) 2004-07-30
CA2213127A1 (en) 1996-09-06
AU4713196A (en) 1996-09-18
EA199700199A1 (ru) 1998-02-26
DE69635798D1 (de) 2006-04-20
UA43396C2 (uk) 2001-12-17
BG101894A (en) 1998-05-29
SI0812318T1 (sl) 2006-06-30
SK115197A3 (en) 1998-02-04
HUP9800631A3 (en) 1998-12-28
SK281879B6 (sk) 2001-08-06
ZA961591B (en) 1996-08-28
EP0812318B1 (en) 2006-02-08
IS2352B (is) 2008-04-15
EE03483B1 (et) 2001-08-15
NO973948L (no) 1997-08-27
NO309474B1 (no) 2001-02-05
DK0812318T3 (da) 2006-06-06
CZ290837B6 (cs) 2002-10-16
AU697610B2 (en) 1998-10-15
US5998613A (en) 1999-12-07
PL321956A1 (en) 1998-01-05
BG63258B1 (bg) 2001-07-31

Similar Documents

Publication Publication Date Title
IL107843A0 (en) Aminomethylene substituted non-aromatic heterocycles
PH31123A (en) Benzimidazole compounds.
ZA924527B (en) Azanorbornane derivatives
FI941022A0 (fi) Spirosykliset piperidiinijohdannaiset
DE60224879D1 (de) Verwendung von dpiv-inhibitoren als therapeutika für krankhafte neurologische zustände
GR3029853T3 (en) Diazabicyclic neurokinin antagonists
SG157231A1 (en) Substituted p-diaminobenzene derivatives
HK1008527A1 (en) 4-aminotetrahydrobenzisoxazole or-isothiazole compounds
AP2003002873A0 (en) Pregabalin lactose conjugates
NO903726L (no) Rensing av 1,1-diklor-1-fluoretan.
IL136306A0 (en) Anticonvulsant and chemical nervous system-active bis(fluorophenyl) alkylamides
MY121206A (en) Aminobenzamide compounds for the treatment of neurodegenerative disorders
PL343758A1 (en) Purification of carboxaldehyde
ES2087813A1 (es) Heterociclos no-aromaticos que contienen nitrogeno bencilamino substituidos.
ES2097688A1 (es) Hexahidroazepinonas y tetrahidrobenzazepinonas sustituidas.
WO2004042405A3 (en) Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 3 (gpr3)

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20090228